RAD51D and breast carcinoma: Notably, a recently published study of the Breast Cancer Association Consortium (BCAC) with more than 60,000 female BC patients and more than 53,000 controls has demonstrated that protein truncation RAD51D variants are associated with a moderately increased BC risk [37].